Skip to main content

Peer Review reports

From: Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country

Original Submission
10 Jun 2023 Submitted Original manuscript
21 Jul 2023 Reviewed Reviewer Report - George Gourzoulidis
29 Jul 2023 Reviewed Reviewer Report - Liliya Eugenevna Ziganshina
31 Jul 2023 Reviewed Reviewer Report - Valentina Lorenzoni
30 Aug 2023 Author responded Author comments - Nikta Shobeiri
Resubmission - Version 2
30 Aug 2023 Submitted Manuscript version 2
1 Sep 2023 Reviewed Reviewer Report - George Gourzoulidis
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
26 Oct 2023 Editorially accepted
4 Nov 2023 Article published 10.1186/s12890-023-02737-5

You can find further information about peer review here.

Back to article page